Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Abb Vie Inc. Transaction History
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna
- $250 Billion
- Q3 2025
A detailed history of Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna transactions in Abb Vie Inc. stock. As of the latest transaction made, Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna holds 1,691 shares of ABBV stock, worth $392,920. This represents 0.16% of its overall portfolio holdings.
Number of Shares
1,691
Previous 1,691
-0.0%
Holding current value
$392,920
Previous $314 Million
24.74%
% of portfolio
0.16%
Previous 0.13%
Shares
12 transactions
Others Institutions Holding ABBV
# of Institutions
4,473Shares Held
1.28BCall Options Held
16.3MPut Options Held
12.5M-
Vanguard Group Inc Valley Forge, PA178MShares$41.3 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.5 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.1 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.68 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $411B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...